Healthcare Triangle regains Nasdaq compliance; investor presentation outlines ~$20M 2025 revenue potential

Healthcare Triangle, Inc.

Nasdaq determined HCTI regained compliance with Listing Rule 5635(a)(1) after amending acquisition agreement to condition share issuance on shareholder approval.
Company received Nasdaq letter on Sept 15, 2025; no further action required; remains listed on Nasdaq.
Investor presentation targets ~$20M potential 2025 revenue with $15.8M committed backlog and $2M YTD wins.
Targets gross margins of 30%+ (EHR), 40%+ (Cloud), 70%+ (AI); operates in $128B+ total addressable market.
Presentation outlines global expansion strategy across EHR, Cloud, and AI verticals.

item 3.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.